Table 1.

Patients surviving after allogeneic transplantation for LAD

	Donor	Age mths	Year BMT	Follow-up (mths)	Conditioning	Graft	Prophyl-axis	Gvhd	Infections	Chimerism
1	MFD	14	1996	156	Bu CY VP16	BM	CyA Mtx	III/IV		Full
2	MFD	18	2006	14	*Flu Mel Cam1H	BM	CyA MMF	II	CMV	MNC 30
3	MFD	3	2007	5	*Flu Treo Cam1H	BM	CyA MMF			Full
4	MSD	78	1994	156	Bu VP16	UCB			Pneumonit is	PMN 44 MNC 64
5	MSD	10	1995	147	Bu CY VP16	BM	CyA		EBV	Full
6	MSD	6	1997	120	Bu CY	BM	CyA	II		MNC 100
7	MSD	2	2000	36	Bu Cy	BM	CyA Mtx Prd			Full
8	MSD	5	2003	36	Bu CY	BM	CyA			Full
9	MSD	4	2003	36	Bu CY ATG	BM	CyA			Full
10	MSD	16	2005	30	Bu Cy ATG	BM	CyA Mtx Prd		CMV	PMN 25 MNC 77
11	MSD	11	2006	24	Bu CY	BM	CyA	I		Full
12	MUD	8	1993	168	Bu CY Cam1G	BM	CyA Mtx			Full
13	MUD	150	1998	71	Bu CY VP16	BM	CyA Mtx		VZV	PMN 63 MNC75
14	MUD	60	2000	72	*Flu Mel Cam1H	BM	CyA		CMV, EBV	PMN100 MNC92
15	MUD	24	2001	72	*Flu Mel Cam1H	BM	CyA	II/III	ADV	Full
16	MUD	36	2001	74	*Flu Mel Cam1H	BM	CyA		Crypto	PMN 87 MNC 93
17	MUD	24	2003	62	*Flu Mel Cam1H	BM	CyA			Full
18	MUD	8	2006	24	Bu CY ATG	BM/CD34		II		MNC 30
19	MUD 1AMM	9	2006	14	*Flu Treo Cam1H	BM	CyA MMF	III/IV	CMV Fungal	Full
20	MUD 1AMM	27	1999	96	Bu CY ATG	UCB	CyA Prd			Full
21	MUD 1AMM	4	1999	50	Bu CY ATG	UCB	CyA Prd	I/II		Full
22	MUD 3AMM	7	2007	12	*Flu Treo ATG	UCB	CyA Prdd			PMN 3 MNC 5
23	MUD 3AMM	7	1997	93	Bu CY ATG	UCB	CyA Prd	I	Candida	Full
24	HAPL HAPL	7	1999	96	Bu CY TP Flu Mel ATG	BM/CD34 BM/CD34		I		Full
25	HAPL(P) HAPL(M) HAPL(M)	2	2000	19	Bu CY ATG Flu aCD3 None	PBSC/CD34 PBSC/CD34 PBSC/CD34				Full
26	HAPL HAPL	22	2003	48	Bu CY ATG Flu Mel TP Cam1G	PBSC/CD34 PBSC/CD34		III		Full
27	HAPL MMFD	4	1993	147	Bu CY ATG TBI CY ARA-C	BM T dep BM T dep	CyA		Candida	PMN 24, MNC10